We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

271 hedge funds and large institutions have $4.27B invested in Bio-Rad Laboratories Class A in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 81 increasing their positions, 119 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $2.8M | Put options by funds: $1.29M

1.45% more ownership

Funds ownership: 76.8% → 78.25% (+1.4%)

0% more capital invested

Capital invested by funds: $4.26B → $4.27B (+$9.01M)

9% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 33

2% less funds holding

Funds holding: 276 → 271 (-5)

32% less repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 119

40% less funds holding in top 10

Funds holding in top 10: 10 → 6 (-4)

Holders
271
Holders Change
-5
Holders Change %
-1.81%
% of All Funds
6.76%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.15%
New
30
Increased
81
Reduced
119
Closed
33
Calls
$2.8M
Puts
$1.29M
Net Calls
+$1.51M
Net Calls Change
+$1.44M

Top Buyers

1
American Century Companies
American Century Companies
Missouri
+$127M
2
Bank of America
Bank of America
North Carolina
+$38.3M
3
PC
Polar Capital
United Kingdom
+$30.4M
4
SC
Samlyn Capital
New York
+$25.9M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$22.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$124M
2
AA
Antipodean Advisors
New York
-$17M
3
ACM
Atlanta Capital Management
Georgia
-$16.1M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$15M
5
BCM
BlueCrest Capital Management
Jersey
-$13.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$376M +$3.28M +14,591 +0.9%
BlackRock
2
BlackRock
New York
$376M -$10.6M -46,897 -3%
ACM
3
Atlanta Capital Management
Georgia
$350M -$16.1M -71,478 -4%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$198M -$925K -4,109 -0.5%
TCM
5
TimesSquare Capital Management
New York
$148M +$9.78M +43,450 +7%
American Century Companies
6
American Century Companies
Missouri
$126M +$127M +566,197 New
State Street
7
State Street
Massachusetts
$120M -$898K -3,989 -0.7%
Wells Fargo
8
Wells Fargo
California
$119M +$2.66M +11,809 +2%
AI
9
Ariel Investments
Illinois
$116M -$11.3M -49,993 -9%
Bank of America
10
Bank of America
North Carolina
$116M +$38.3M +170,370 +48%
UBS AM
11
UBS AM
Illinois
$91.4M -$3.56M -15,829 -4%
FWIA
12
Fort Washington Investment Advisors
Ohio
$80.2M -$4.75M -21,130 -6%
HCM
13
Hitchwood Capital Management
New York
$77.8M -$11.3M -50,000 -13%
AllianceBernstein
14
AllianceBernstein
Tennessee
$73.3M +$339K +1,505 +0.5%
NIMC
15
NWQ Investment Management Company
California
$63.9M -$5.75M -25,539 -8%
Fisher Asset Management
16
Fisher Asset Management
Washington
$61.7M -$483K -2,148 -0.8%
CRM
17
Cramer Rosenthal McGlynn
Connecticut
$61.6M -$9.37M -41,648 -13%
EIP
18
Epoch Investment Partners
New York
$55.5M +$5.5M +24,420 +11%
Manulife (Manufacturers Life Insurance)
19
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$54.7M +$3.57M +15,856 +7%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$54.1M -$1.21M -5,379 -2%
PI
21
Putnam Investments
Massachusetts
$49.1M +$2.01M +8,934 +4%
Citadel Advisors
22
Citadel Advisors
Florida
$47.7M +$6.73M +29,910 +16%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$46M -$3.43M -15,236 -7%
Northern Trust
24
Northern Trust
Illinois
$45.9M -$1.82M -8,081 -4%
CCM
25
Clearfield Capital Management
New York
$43.4M -$1.58M -7,028 -3%
1
2 3 4 5

BIO Hedge Fund Activity: Q3 2017 in Review

271 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2017, worth a combined $4.27B — up 0.21% from $4.26B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of BIO and 30 opened new positions — a net loss of 3 holders — while 119 trimmed existing stakes and 81 added.

The largest buyer was American Century Companies, opening a new position worth an estimated $127M. The largest seller was Fidelity Investments, cutting an estimated $124M.

  • 271 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2017, down from 276 in Q2 2017.
  • Funds reported $4.27B of Bio-Rad Laboratories Class A stock for Q3 2017, up 0.21% quarter-over-quarter.
  • 30 funds opened new Bio-Rad Laboratories Class A positions in Q3 2017 and 33 closed out, a net change of -3 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2017 was American Century Companies, an estimated $127M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2017 was Fidelity Investments, an estimated $124M sold.

Based on aggregated 13F filings for Q3 2017.